CoChat

Omapatrilat—the story of Overture and Octave

Coats, Andrew J.S · 2002 · International Journal of Cardiology

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Abstract

At the American College of Cardiology in March two major trials were presented. The publicity surrounding the two could not have been more different. The LIFE demonstrated clear superiority of losartan-based therapy over atenolol-based therapy for the treatment of hypertension. It was published the same week in the Lancet and received major press coverage all over the world. The OVERTURE (Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events) study in contrast received a subdued reception, very little publicity and is yet to be published. 5770 NYHA class II-IV heart failure patients (LVEF<or=30%, recent heart failure hospital admission) were randomised and uptitrated to either 10 mg BD of Enalapril or 40 mg once a day Omapatrilat. The primary end-point of all cause mortality or heart failure related hospitalisation did not differ significantly: 914/2884 for Enalapril and 914/2886 for Omapatrilat (hazard ratio 0.94, CI's 0.86-1.03, P=0.187). Mortality was also similar: 509 for Enalapril and 477 for Omapatrilat (hazard ratio 0.94, CI's 0.83-1.07, P=0.339). Omapatrilat was as good as Enalapril but not better. The worrying trend was however, that angioedema was more common with Omapatrilat; 24 (0.8%) versus 14 cases (0.5%). The OCTAVE (Omapatrilat Cardiovascular Treatment Assessment Versus Enalapril) study was also presented at this time. 25,267 hypertensives were randomised to Omapatrilat or enalapril and a difference of approximately 3 mmHg in favour of Om…

Overview

Integrity signals

Registry

Crossref · 10.1016/s0167-5273(02)00389-3

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 17 references

Research works printed but not linked: 1

  1. Angioedema due to ACE inhibitors: common and inadequately diagnosed. Prescrire Int 1998;7(35):92–93.

Cited by

See all 107

Metadata

Authors
Coats, A. J. S.
Affiliations
Royal Brompton Hospital (GB)
Corresponding author
Coats, Andrew J.S
Venue
International Journal of Cardiology
Publisher
Elsevier BV
Published
2002-11
Volume
86
Issue
1
Pages
1-4
ISSN
0167-5273 (ISSN-L)
OpenAlex
W2168106055
Cited by
107
References
17
Citations by year
2026: 1 · 2025: 2 · 2024: 2 · 2022: 1 · 2021: 6 · 2020: 2 · 2019: 3 · 2018: 1 · 2017: 5 · 2016: 2 · 2015: 2 · 2013: 2 · 2012: 3
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • International Journal of Cardiology (publishedVersion)
  • PubMed (publishedVersion)
  • UEA Digital Repository (University of East Anglia) (submittedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
Keywords
omapatrilat, heart failure, ACE inhibitors, enalapril, losartan, atenolol, hypertension, drug trials, media coverage
MeSH terms
Angiotensin-Converting Enzyme Inhibitors, Antihypertensive Agents, Clinical Trials as Topic, Drug Industry, Enalapril, Heart Failure, Humans, Pyridines, Research Support as Topic, Thiazepines, Treatment Failure

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Omapatrilat—the story of Overture and Octave. https://app.cochat.ai/papers/10.1016/s0167-5273(02)00389-3
The paper
Coats, A. J. S. (2002). Omapatrilat—the story of Overture and Octave. International Journal of Cardiology. https://doi.org/10.1016/s0167-5273(02)00389-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.